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ABSTRACT
RING ﬁnger protein 13 (RNF13) is a novel E3 ubiquitin
ligase whose expression is associated with cancer
development. However, its speciﬁc role in cancer pro-
gression and metastasis remains unclear. Here, a
B16F10/LLC experimental pulmonary metastatic model
was developed to examine the formation of metastatic
foci in the lung. A greater number of tumor colonies
were observed in the lungs of RNF13-knockout (KO)
mice than in their wild-type (WT) littermates, whereas no
signiﬁcant differences in tumor size were observed
between the two groups. In short-term experiments, the
number of ﬂuorescently-labeled B16F10 cells increased
remarkably in RNF13-KO lungs at early time points,
whereas clearance of tumor cells from the blood was not
affected. These results indicated that RNF13 may inhibit
the colonization of B16F10 cells in the lung. Assessment
of the concentration of various cytokines in tumor
bearing lungs and blood did not detect signiﬁcant dif-
ferences between the blood of RNF13-KO and WT mice;
however the levels of GM-CSF were signiﬁcantly
reduced in RNF13-KO tumor bearing lungs, which may
have guided more B16F10 cells to migrate to the lungs.
This was conﬁrmed by lower GM-CSF concentrations in
conditioned media from the culture of RNF13-KO lung
slices. Collectively, our results suggest that host RNF13
affects the concentration of GM-CSF in tumor-bearing
lungs, leading to a reduction in the colonization of
metastatic tumor cells in the lung.
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INTRODUCTION
Metastasis is the main cause of cancer-related death and it
occurs through a cascade of events (Talmadge and Fidler,
2010). The metastatic process begins with the local invasion
of malignant cells, followed by intravasation of these cells into
nearby blood and lymphatic vessels, transit through the
vascular system, extravasation to target organs, and the
formation of micrometastases. Finally, these micrometastatic
lesions grow into macroscopic tumors. In this process, tumor
cells from a primary tumor successfully invade and colonize a
distant organ (Hanahan and Weinberg, 2011). Despite the
fact that millions of tumor cells are shed into the vasculature,
few metastatic tumor cells survive and form secondary
tumors; however, a similar metastatic process results in dif-
ferent outcomes among patients (Luzzi et al., 1998). In recent
decades, to explain these discrepancies, researchers have
focused mainly on the differences between cell-autonomous
phenomena in malignant tumors. However, during the multi-
step process of tumor metastasis, the host microenviron-
ment, which contains non-cancerous host factors, plays an
active and indispensable role. One possible explanation was
that the host microenvironment may inﬂuence the metastatic
efﬁciency of tumor cells, resulting in a small subpopulation of
cells capable of completing the steps required to successfully
colonize a distant site, while differences in host factors
among individuals may lead to the different outcomes of
patients (Irmisch and Huelsken, 2013; Nguyen et al., 2009).
As early as 1889, Stephen Paget proposed the “seed and
soil” theory of metastasis, which suggested that speciﬁc
organ microenvironments (the ‘soil’) could inﬂuence the
growth of tumor cells (the ‘seeds’) (Paget, 1989). The
important role of the host microenvironment in the invasion
and metastasis of tumor cells is widely accepted. The
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interaction between tumor cells and the host microenviron-
ment, which is referred to as “the tumor microenvironment”,
determines the ﬁnal fate of these metastatic tumor cells
(Spano and Zollo, 2012).
RING ﬁnger protein 13 (RNF13) is an E3 ubiquitin ligase
that was ﬁrst identiﬁed as a gene whose expression changes
in chicken embryo brain (CEB) cells in response to binding to
the extracellular matrix molecule cytotactin/tenascin (CT/TN)
(Tranque et al., 1996). It was later found to be ubiquitously
expressed in various chicken, mouse, and human tissues
(Bocock et al., 2009; Zhang et al., 2009; Zhang et al., 2010).
RNF13 is involved in many physiological processes. Our
previous work showed that deletion of RNF13 in mice leads
to a signiﬁcant deﬁcit in spatial learning and accelerates
muscle regeneration, which is mediated by macrophage-
secreted cytokines (Meng et al., 2014; Zhang et al., 2013).
Emerging evidence suggests that RNF13 functions in cancer
development. Our previous research in pancreatic ductal
adenocarcinoma showed that RNF13 expression is signiﬁ-
cantly associated with histological grading (Zhang et al.,
2009). Human tissue microarray analysis also suggested an
association between RNF13 expression and human colon
cancer development, as the RNF13 protein is expressed at
higher levels in human colon cancer samples than in control
samples. Microarray analysis of multiple tumor samples
suggested a link between RNF13 expression and various
human tumors including melanoma (Jin et al., 2011). Van
Dijk et al. (2014) identiﬁed loss-of-function mutations of
RNF13 in tumor tissues isolated from several cancer
patients with different tumor types, including lung and skin
cancer. These data indicated that RNF13 may function
during cancer development.
Nonetheless, many aspects of the molecular mechanisms
that link host gene function, the tumor microenvironment,
and the establishment of tumor colonies in a distant organ
remain unresolved. In this regard, experimental animal
models may provide valuable insight into the molecular
mechanisms linking host gene expression and pulmonary
colonization of tumor cells. In the present study, we estab-
lished a B16F10 experimental metastatic model in RNF13-
knockout (KO) mice and tracked the changes of tumor cells
during this experimental metastasis. Our results indicated
that the host RNF13 could inhibit experimental lung metas-
tasis. The absence of host RNF13 lowered the concentration
of GM-CSF in tumor bearing lungs, leading to enhanced
invasion of melanoma cells and increased lung colonization.
These data suggest that RNF13 plays a regulatory role in
this process.
RESULTS
Elevated levels of metastasis in the lungs of mice
lacking RNF13
Our previous work suggested a link between RNF13 and
tumor progression. A study that included 72 pancreatic
ductal adenocarcinoma (PDAC) patients showed that
RNF13 was overexpressed in 30 tumor samples, and its
expression was signiﬁcantly associated with histological
grading (Zhang et al., 2009). In the present study, RNF13
was regarded as a host factor. To determine whether host
RNF13 could inﬂuence cancer progression, in particular
cancer metastasis, RNF13-KO mice were used to establish
a pulmonary metastatic model. B16F10 melanoma cells
were injected into the dorsal tail vein of the RNF13-KO mice
and their WT littermates, which resulted in increased
metastasis in RNF13-KO mice bearing B16F10 cells for 14
days (Fig. 1A). The number of metastatic foci on the lung
surface of RNF13 KO mice was higher than that of their WT
littermates (Fig. 1B). No signiﬁcant differences in lung tumor
size were observed between RNF13-KO and WT mice
(Fig. 1C), and these results were conﬁrmed by histological
analysis (Fig. 1D). In the LLC experimental metastasis
model, equal numbers of LLC cells were injected by tail vein,
and metastasis was analyzed after 21 days. RNF13-KO
mice showed a larger metastatic area in the lung and a
heavier tumor-bearing lung tissue than their WT littermates
(Fig. 1E and 1F). Pathological sections showed that tumor
number was increased in RNF13-KO mice (Fig. S1). In mice
bearing LLC cells for 27 days, the eight RNF13-KO mice
developed lung cancer. Among these RNF13-KO mice, 1/8
died from the tumor metastasis, and 1/8 developed pul-
monary, diaphragmatic, and mesenteric metastasis, while no
tumors were detected in other tissues besides the lung in six
WT mice. In these B16F10 metastatic models, RNF13 deﬁ-
ciency had no effect on the distribution of individual meta-
static foci, suggesting that local growth was unperturbed. To
further assess local growth effects, LLC cells were injected
subcutaneous into the dorsal ﬂank of RNF13-KO and WT
mice. The real-time size of tumors was measured every two
days and tumor weight was measured at 22 days after
injection (Fig. S2A and S2B). The results showed no sig-
niﬁcant differences in tumor size and tumor weight between
RNF13-KO mice and their WT littermates.
Host RNF13 affects B16F10 cell colonization in the lung
during the early stages of the experimental metastasis
In our tumor models, host RNF13 deﬁciency had no effect on
tumor growth, whereas it caused an appreciable increase in
metastasis. To examine the mechanism of increased
metastasis in RNF13-KO mice, the distribution of B16F10
cells and metastatic clones were examined in the lung at
early time points after cell injection. Equal numbers of
B16F10 cells were injected through the tail vein into RNF13-
KO mice and their WT littermates. At 2 and 4 days after
injection, mice were sacriﬁced and B16F10 bearing lungs
were collected. Since there were no visible metastases on
the surface of the lungs at these two time points, lung tissues
were ﬁxed and sectioned for H&E staining. Histological
analysis showed few single B16F10 cells in lung tissues at 2
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days; micrometastases composed of several tumor cells
appeared in the lungs at 4 days (Fig. 2A). Data quantiﬁcation
indicated that the number of either single tumor cells (2 days)
or micrometastases (4 days) was higher in RNF13-KO mice
than in their WT littermates (Fig. 2B). To determine whether
RNF13 functions at an earlier time point in this experimental
model, BCECF-labeled B16F10 cells were injected into the
tail vein of mice and lungs were isolated at 6 h and 24 h.
RNF13-KO lungs contained signiﬁcantly more B16F10 cells
than WT mice, as shown in cryosections (Fig. 2C and 2D).
For 6–72 h analyses, CFSE labeled B16F10 cells were
injected into the tail vein and the isolated perfused lungs
were digested to prepare single cell suspensions. The rela-
tive percentage of CFSE-labeled B16F10 cells was deter-
mined by ﬂow cytometry (Fig. 2E). A signiﬁcantly greater
number of B16F10 cells were recovered from RNF13-KO
mice than from WT mice at 6 h, 24 h, 48 h, and 72 h
(Fig. 2F). These results indicated that host RNF13 may
inﬂuence the colonization of metastatic tumor cells in the
lung.
The deﬁciency of host RNF13 had no effect
on the clearance of B16F10 cells from the blood
In our B16F10 experimental pulmonary metastatic model,
tumor cells were injected into the circulation of mice and
allowed to travel in the vascular system. Differences in the
rapid clearance of cells from the blood may reﬂect the
number of B16F10 cells available for lung colonization in
RNF13-KO mice. To determine whether rapid clearance from
blood was affected in RNF13-KO mice, CFSE labeled
B16F10 cells were injected into the tail vein of mice, and
ﬂuorescent cells were detected by ﬂow cytometry in the
lungs and blood. Consistent with our previous results,
RNF13-KO mice had a greater number of ﬂuorescent
B16F10 cells in the lung than WT mice, whereas analysis of
blood samples from the same mice bearing B16F10 cells for
6 h, 24 h, 48 h, and 72 h showed no signiﬁcant differences in
the number of B16F10 cells in the two groups (Fig. 3A).
Quantitative analysis showed no signiﬁcant differences in
the percentage of B16F10 cells in the blood between WTand
RNF13-KO mice (Fig. 3B). These results indicated that the
deﬁciency of host RNF13 did not affect B16F10 cell clear-
ance from the blood.
Reduced GM-CSF concentration in the lungs
of RNF13-KO mice
Immune cells and immune factors play a critical role in
metastasis. Mechanisms that enhance the probability of
CTCs successfully metastasizing to a distant organ mainly
rely on physical interaction with leukocytes. Leukocytes in
KO
   
   
   



















































Figure 1. Enhanced experimental pulmonary metastasis in host mice with RNF13 gene deletion. (A) Representative image of
pulmonary metastatic foci produced 14 days after intravenous injection of B16F10 cells. Scale bar = 1 cm. (B) Numbers of
experimental pulmonary B16F10 metastases in the whole lung (*, P = 0.0434. n = 8). (C) Size distributions of B16F10 metastatic foci
(ns, P = 0.6369. n = 8) (D) Representative H&E staining of sections of lungs from wild type and RNF13-KO mice treated as in (A).
Arrows point to metastatic foci. Magniﬁcation 40×. (E) Representative image of pulmonary metastatic foci produced 21 days after
intravenous injection of LLC cells. (F) Tumor-bearing lung weights of RNF13-KO and wild type mice 21 days after bearing LLC tumors
(*, P = 0.0178. n = 6).
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the blood support tumor cell colonization in metastatic
organs (Man et al., 2011). However, the percentage of
leukocytes (CD45-positive cells) was not increased in the
blood of RNF13-KO mice at 6–72 h (Fig. S3). Furthermore,
we hypothesized that a greater number of leukocytes inter-
acting with B16F10 cells in RNF13-KO mice may enhance
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colonization in the lungs. To test this hypothesis, CFSE
labeled B16F10 and CD45+ cells were detected in blood
24 h after injection of B16F10 cells into the blood of RNF13-KO
and WT mice. Quantiﬁcation of the number of CFSE and
CD45 double positive cells indicated that the percentage of
B16F10-engaged leukocytes did not differ signiﬁcantly
between RNF13-KO and WT mice (Fig. 4A and 4B). Similar
results were obtained at 6 h, 48 h, and 72 h. The quantiﬁ-
cation of B16F10 relative leukocytes conﬁrmed these ﬁnd-
ings (Fig. 4B). These results demonstrate that the lack of
host RNF13 had no effect on the number of B16F10 relative
leukocytes. Next, we evaluated the changes of cytokines in
the blood and lungs from RNF13-KO and WT mice bearing
B16F10 cells for 24 h and 4 days (PBS was used as control).
Eighteen different cytokines or chemokines were detected
by Luminex including GM-CSF, LIF, LIX, IL-1α, IL-1β, IL-4,
IL-6, IL-10, IL-12 (P40), IL-12 (P70), IL-17, IFN-γ, TNFα,
MIP-1α, MIP-1β, MIP-2, MCP-1, and RANTES. The con-
centration of these cytokines in the blood of RNF13-KO mice
was comparable to that in WT mice (Fig. 4C). The results
show that the concentration of GM-CSF in the lungs of
RNF13-KO mice was lower than that in WT mice after
bearing B16F10 cells (Fig. 4D).
Enhanced invasion of B16F10 cells mediated by
RNF13-KO conditioned media requires decreased
GM-CSF
To determine whether the low concentration of GM-CSF in
RNF13-KO lungs enhanced the invasive ability of B16F10
cells, we performed in vitro invasion assays (Fig. 5A). In
these experiments, we used conditioned media generated
by culturing slices of melanoma bearing lung tissues from
either RNF13-KO mice or their WT littermates as chemoat-
tractants. Assessment of the concentration of cytokines in
conditioned media showed that, similar to the B16F10
bearing lungs, GM-CSF concentration was lower in condi-
tioned media from RNF13-KO lungs (Fig. 5C). Transwell
experiments showed that either nonconditioned media or the
conditioned media generated by culturing WT lung slices
only slightly stimulated the invasion of B16F10 cells from the
upper to the lower chamber, whereas the conditioned media
obtained from the culture of RNF13-KO lung slices dramat-
ically stimulated the invasion of B16F10 melanoma cells
(Fig. 5B and 5D). To determine whether this increased
number of migrated cells was due to the reduction of GM-
CSF concentration in RNF13-KO conditioned medium,
recombinant GM-CSF was added to RNF13-KO conditioned
media, which led to a reduction in the number of migrated
cells (Fig. 5B and 5D). This means GM-CSF could suc-
cessfully rescue the increased migrated cells caused by
RNF13-KO conditioned media, and this rescue effect is in a
dosage dependent manner (Fig. S4A and S4B). Taken
together, our data indicate that host RNF13 may affect
melanoma cell colonization in the lung by modulating the
concentration of GM-CSF in the target organ, which may
reduce the amount of B16F10 cells available for homing to
the lung.
DISCUSSION
RNF13 is an E3 ubiquitin ligase, and its association with
pancreatic cancer was previously reported by our lab.
RNF13 cannot be detected in pancreatic ductal epithelial
cells, whereas it is expressed in pancreatic carcinoma pre-
cancerous lesion (chronic pancreatitis and pancreatic
intraepithelial neoplasia) and pancreatic ductal adenocarci-
noma (Zhang et al., 2009). These ﬁndings suggested that
RNF13 may be involved in inﬂammation-associated car-
cinogenesis. To determine whether the lack of RNF13
affected the formation of spontaneous tumors and the sur-
vival rate, three different genotypes of mice (RNF13+/+,
RNF13+/−, RNF13−/−) were observed for a period of 20
months or longer. Our results showed that the earliest time of
death in RNF13-KO mice (12.2 months) and heterozygous
mice (12.4 months) was earlier than that of WT mice (17.9
months), and their survival rate was lower (not signiﬁcant)
(Fig. S5). Analysis of the causes of death showed that the
rate of cancer-related death was similar between RNF13-KO
and WT mice. These results indicated that the lack of RNF13
did not affect the occurrence of cancer. However, our results
did not exclude the possibility that RNF13 could function
under pathological conditions by affecting the disease pro-
cess, or its involvement in processes associated with cancer
development.
In the present study, we conﬁrmed that host RNF13 could
block the colonization of metastatic tumor cells. Injection of
B16F10 melanoma cells or LLC cells into the tail vein of mice
enhanced pulmonary metastasis in RNF13-KO mice. In our
previous research, RNF13 was downregulated during
chicken skeletal muscle development, and RNF13 inhibited
myoblast proliferation in chicken embryos (CFM) (Zhang
et al., 2010). Therefore, we investigated whether deletion of
host RNF13 may affect tumor cell proliferation and lead to
enhanced metastasis. To test this hypothesis, we measured
b Figure 2. Host RNF13 affects lung colonization. (A) H&E
staining of lung tissue sections from RNF13-KO and wild type
mice at 2 days and 4 days after injection of B16F10 cells.
Arrows point to micrometastases. Magniﬁcation: 400×. (B) The
number of micrometastases per mouse in the same sections as
in (A), (*, 2 days P = 0.0407. n = 5, 4 days P = 0.0161. n = 5).
B16F10 cells labeled with BCECF or CFSE were injected into
mouse tail veins. (C) Fluorescent B16F10 cells (BCECF-
positive) in cryosections at 6 h and 24 h after injection.
(D) Quantiﬁcation of ﬂuorescent B16F10 cells in all ﬁve lung
lobes in cryosections (*, 6 h P = 0.0260. n = 6, 24 h P = 0.0121.
n = 6). (E) CFSE labeled cells (relative to total suspended lung
cells) were also determined using ﬂow cytometry at 6–72 h after
injection. (F) Quantiﬁcation of labeled cells in (E) by ﬂow
cytometry (*, 6 h P = 0.0242. n = 6, 24 h P = 0.0481. n = 6, 48 h
P = 0.0472. n = 5, 72 h P = 0.0420. n = 5).
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the size of metastatic foci in the lungs and found no signiﬁ-
cant differences between RNF13-KO and WT mice. Fur-
thermore, we found that the lack of host RNF13 did not
promote in situ LLC tumor growth.
It is reported that in animal studies, following intravenous
injection, 60%–100% of the injected cancer cells are initially
arrested in the lungs but after 24 h only 0.01% of circulating
tumor cells (CTCs) could survive and eventually extravasate
to form metastatic tumors (Fidler, 1970; Nicolson, 1979).
Circulating tumor cells faced numerous challenges in blood
before they could extravasate into distant organs. Mechani-
cal destruction caused by the blood circulation and surveil-
lance by immune cells contribute to making the blood
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Figure 3. B16F10 cells in blood. B16F10 cells labeled with CFSE were injected into mouse tail veins. (A) After 6–72 h, blood
samples were collected directly from the heart and the percentage of CFSE-labeled cells was determined by the ﬂow cytometry (SSC
= side scatter). Note that blood from a control mouse (no B16F10 injection) contained essentially no CFSE-labeled cells.
(B) Quantiﬁcation of labeled cells by ﬂow cytometry (ns, 6 h P = 0.6831. n = 5, 24 h P = 0.8159. n = 6, 48 h P = 0.8221. n = 5, 72 h P =
0.4778. n = 5).
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2009). In consideration of this issue, the differences of rapid
clearance from blood could potentially result in more B16F10
cells being available for lung colonization in RNF13-KO
mice. Therefore, we detect the percentage of B16F10 cells in
blood in the short-term experiments (6–72 h after B16F10
injection). Although large discrepancy existed between
individuals, the percentage of B16F10 cells in the blood was
not increased in RNF13-KO mice. Moreover, further
research using the lung tissues from same mice indicated an
increased percentage of B16F10 cell available in the lung by
ﬂow cytometry. Furthermore, a greater number of B16F10
cells were detected in the lung tissues of RNF13-KO mice by
frozen section at 6 h and 24 h or by H&E staining at day 2
and day 4. These results suggested that the loss of host
RNF13 leading to increased B16F10 cell extravasation and
homing.
We detected the concentration of 18 types of cytokines or
chemokines in blood and tumor bearing lung tissues. The
results showed that GM-CSF concentration was signiﬁcantly
decreased in RNF13-KO tumor bearing lungs. GM-CSF is an
anti-tumor factor that is widely used as immune adjuvant in
the treatment of many cancers including melanoma (Dranoff,
2002, 2003; Spitler et al., 2014). Tumor-derived GM-CSF is
an important regulator of inﬂammation and immune sup-
pression within the tumor microenvironment (Bayne
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Figure 4. Immune cells and cytokines detection in tumor bearing blood or lung tissues. (A) At 24 h, blood was collected and
analyzed for the presence of CFSE-B16F10. CFSE+ cells (gated as in left panels) were stained with CD45-APC (right panels). Note
that CFSE+ cells are essentially absent in a sample from a control mouse with no B16F10 injection (top panel). (B) CFSE+ cells from
the blood were analyzed to determine the percentage of CD45-engaged B16F10 cells at different time points (as in part A) (ns, 6 h
P = 0.5349. n = 5, 24 h P = 0.4896. n = 6, 48 h P = 0.3812. n = 7, 72 h P = 0.7873. n = 5). (C) The concentration of GM-CSF in blood
after bearing tumor for 24 h and 4 days in wild type and RNF13-KO groups. (ns, 0 h P = 0.6168. n = 5, 24 h P = 0.4982. n = 5,4 days
P = 0.8897. n = 5). (D) GM-CSF was signiﬁcantly reduced in RNF13-KO lungs compared with the wild type controls after bearing
B16F10 cells (ns, 0 h P = 0.4223. n = 5; *, 24 h P = 0.0358. n =5, 4 days P = 0.0494. n = 5).
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enhances host responses through improved tumor antigen
presentation by recruited immune cells, such as dendritic
cells, leading to a reduction in metastasis (Williams et al.,
2010). Eubank et al. (2009) found that GM-CSF can re-ed-
ucate macrophages to reduce metastases in murine breast
cancer. We therefore assumed that the low concentration of
GM-CSF in RNF13-KO lungs could lead to an increase in
metastatic B16F10 cells in the lung. To test this, we detected
the concentration of cytokines in conditioned media from the
culture of lung tissues, which showed that GM-CSF was
lower in RNF13-KO than in WT mice media. Use of the
conditioned media as a chemoattractant for in vitro invasion
assays showed that the media from RNF13-KO cultures
promoted B16F10 cell invasion. Rescue experiments further
conﬁrmed this result.
Our previous work showed that snapin is a substrate of
RNF13. It was found that at hippocampal synapses snapin
was ubiquitinated by RNF13 which promoted the association
of snapin with SNAP-25 and regulated the function of
SNARE complex (Zhang et al., 2013). According to the
function role of SNARE complex in cytokine secretion, we
considered that RNF13 may be involved in GM-CSF secre-
tion through snapin (Stanley and Lacy, 2010). In this study
we detected snapin expression between wild type and
RNF13-KO mice after bearing B16F10 cells. The result
indicated that snapin expression did not change in the
RNF13-KO lungs (Fig. S6A and S6B). But whether RNF13
functions in metastasis are mediated through snapin or
another substrate needs our further studies. Moreover, in
order to ﬁnd out whether the reduction of GM-CSF could lead
C DA

















































Figure 5. Conditioned media from lung tissues of RNF13-KO mice promoted invasion of B16F10 cells in Transwell assays.
(A) Graphic representation of the methods used for determining B16F10 cell invasion in response to conditioned media. (B) The
conditioned medium obtained from culturing WT lungs slices only modestly stimulated the invasion of B16F10 cells. The conditioned
medium from RNF13-KO lungs caused a signiﬁcantly higher level of cell invasion. Addition of GM-CSF to this medium rescued the
increased migration B16F10 cells. Normal medium was used as a negative control in this experiment. (C) GM-CSF concentration in
the conditioned media used in (B). Conditioned media from lung tissues of RNF13-KO mice was signiﬁcantly reduced relative to that
from WT mice (*, P = 0.0174). (D) The number of migrated cells was quantiﬁed (ns, P = 0.2785; *, P = 0.0478; **, P = 0.0014).
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to the expression changes of other genes which lead to the
enhanced metastasis in RNF13-KO mice, we also detected
expression patterns of several genes related to metastasis
(Fig. S6C). But there are no signiﬁcant differences between
WT and RNF13-KO mice in these genes, including
PECAM1, VCAM1, MAC-1, E-selectin, VE-cadherin, VEGF,
and MMP9. Therefore, the exact mechanism of RNF13
function in metastasis needs to be systematically investi-
gated in the future study.
In the present study, we showed that the deﬁciency of
host RNF13 decreased the concentration of GM-CSF in the
lungs, which facilitates metastatic cell colonization and leads
to enhanced metastasis in RNF-13 KO mice. These ﬁndings
may lead to the identiﬁcation of novel therapeutic targets for
the treatment of cancer metastasis.
MATERIALS AND METHODS
RNF13-KO mice
RNF13-KO mice were generated as described previously (Zhang
et al., 2013) and housed under pathogen-free conditions at the
Laboratory animal center of Peking Union Medical College. Geno-
type of all breeding pairs was conﬁrmed by PCR analysis. In all
studies, RNF13-KO mice, 7–12 weeks old, were compared with lit-
termates of the same age and gender. Animal studies were con-
ducted in accordance with the guidelines of the Animal Ethics
Committee of Peking Union Medical College.
Cells
The murine melanoma cell line B16F10 and Lewis lung carcinoma
(LLC) cell line were obtained from American Type Culture Collection
(Manassas, VA). Cancer cell lines were cultured in a humidiﬁed
atmosphere of 5% CO2 using DMEM containing 10% fetal bovine
serum, 100 U/mL penicillin G, and 0.1 mg/mL streptomycin. Tumor
cell viability was greater than 95%, as determined by Trypan blue
exclusion.
In vivo tumor experiments
For assessment of local tumor growth, a suspension of 5 × 106 LLC
cells in PBS was injected subcutaneously into the dorsal region of
RNF13-KO mice and their wild-type (WT) littermates. Starting at 8
days after implantation, when palpable tumors formed, tumor size
was measured every 3 days and tumor volume was calculated using
the formula length × width2 × 0.5. Mice were sacriﬁced 22 days after
cell injection and tumor masses were collected and weighed.
For establishment of an experimental pulmonary tumor metas-
tasis model, B16F10 melanoma cells were resuspended in PBS,
and 5 × 105 cells (in 0.2 mL PBS) were injected into mice via lateral
tail vein. Mice were killed 14 days after injection and tissues were
isolated and ﬁxed in 10% neutral-buffered formalin. Lung lobes were
photographed and metastatic foci on the surface of the lung were
counted and their size was determined (using NIH Image J). For LLC
tumors, the same procedure was used except that the cell number
for tail vein injection was 1 × 105 and mice were sacriﬁced 21 days
after injection.
In the short-term metastasis model, B16F10 cells were labeled
with CFSE or BCECF-AM (Molecular Probes, Invitrogen), and
5 × 105 labeled B16F10 cells (in 0.2 mL PBS) were injected into the
tail vein of mice. Control mice were injected with PBS. At 6 h after
injection, mice were sacriﬁced and blood samples were collected
directly from the heart into tubes containing 10 mmol/L EDTA in PBS
to prevent coagulation. Erythrocytes were subsequently lysed fol-
lowed by the detection of ﬂuorescent B16F10 cells by ﬂow cytom-
etry. All ﬁve lobes of lungs were collected for later use in
cryosections. Ten discontinuous sections were made for each lobe
and more than 10 random ﬁelds were marked for each lobe; meta-
static foci were visualized and counted using a ﬂuorescence
microscope. In some experiments, after blood collection, mice were
perfused with 20 mL of PBS with 2 mmol/L EDTA until the lungs and
liver appeared white. After perfusion, lungs were collected and
processed by gentle mechanical disruption with forceps followed by
enzymatic digestion with 2.4 U/mL dispase gradeII (Roche),
0.25 U/mL liberase TM Research Grade medium thermolysin
(Roche), 20 Kunitz units/mL DNase (Sigma), and 20 U/mL hyalur-
onidase (Sigma), all dissolved in PBS. Tissue suspensions (5–6 mL
per lung) were incubated at 37°C for 45 min with vigorous pipetting
every 15 min to help tissue digestion. Cells were then strained
through a 70 μm nylon mesh and suspended in PBS for detection by
ﬂow cytometry.
Immune cell assay in blood
Blood and lung tissues were collected from RNF13-KO mice and
their WT littermates bearing CFSE labeled B16F10 cells for 24 h,
48 h or 72 h. For blood assays, erythrocytes were subsequently
lysed and for lung assays, tissues were perfused and digested as
described above. Cells were then stained with ﬂuorescently labeled
monoclonal antibodies against CD45, washed in FACS buffer [PBS
with 5% fetal bovine serum (FBS) and 2 mmol/L EDTA] and ana-
lyzed immediately by ﬂow cytometry (using a BD Accuri™ C6 ﬂow
cytometer, BD Biosciences). Data were analyzed using CFlow®
sampler analysis software (BD Biosciences).
Cytokine detection
Lung tissues bearing B16F10 tumors for 24 h and 4 days were
collected and digested with tissue lysis buffer (100 mmol/L TrisCl pH
8.0 buffer containing 0.1 mmol/L EDTA, 150 mmol/L NaCl, 1%
NP-40, 20 mmol/L NaF, 1 mmol/L Na3VO4, 1 mmol/L NaH2PO4, and
complete EDTA-free protease inhibitor cocktail). The samples were
centrifuged to remove debris and assayed immediately. For blood
detection, 24 h after the injection of B16F10 cells, blood was col-
lected and clotted for at least 30 min before centrifugation to obtain
serum for the next assay. Luminex assays (MILLIPLEX® MAP Kit
Mouse cytokine/chemokine 96 well plate assay, Millipore) were
performed for the detection of the following 18 cytokine or chemo-
kine types: GM-CSF, LIF, LIX, IL-1α, IL-1β, IL-4, IL-6, IL-10, IL-12
(P40), IL-12(P70), IL-17, IFN-γ, TNFα, MIP-1α, MIP-1β, MIP-2,
MCP-1, and RANTES.
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Preparation of conditioned medium
B16F10 cells were injected into the tail vein of RNF13-KO mice and
their WT littermates 24 h before perfused lungs were sectioned
(2 mm2) and cultured in DMEM supplemented with 10% FBS for
90 min. The organ culture media were then centrifuged, and the
supernatants were stored at −80°C until used as chemoattractants in
the invasion assay.
In vitro invasion assays
Twelve-well chambers ﬁtted with 8.0 μm pore size polycarbonate ﬁl-
ters (Corning) and Matrigel-coated (BD Biosciences) were used to
perform the invasion assays. The lower compartment was ﬁlled with
1 mL of medium containing various chemoattractants. These
chemoattractants included conditioned medium from the culture of
B16F10-bearing WT and RNF13-KO lung sections and DMEM con-
taining 10% FBS with recombinant GM-CSF (10 ng/mL); DMEM
containing 10%FBS alone served as a control. B16F10 cells (5 × 104)
were resuspended in 500 µL of DMEM containing 0.1% bovine serum
albumin and placed in the upper chamber. Cell invasion through the
porous ﬁlter was allowed to take place for 24 h in a humidiﬁed atmo-
sphere of 5%CO2 at 37°C. The upper surface of the ﬁlter was scraped
with moist cotton swabs to remove nonmigrated cells, and then the
cells attached to the lower surface of the ﬁlters were stainedwith eosin
and DAPI. The invaded cells were photographed and counted in
triplicate and at least 10 different ﬁelds for each repeat were analyzed.
Statistical analysis
Data are expressed as the mean ± SE. The statistical signiﬁcance of
differences between two means was calculated using Student’s
t test. P values < 0.05 were considered statistically signiﬁcant.
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